Gene therapy for α-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene

Hepatology

Volumn 23, Issue 6, 1996, Pages 1359-1368

  Kanai, Fumihiko ^a,b,e   Shiratori, Yasushi ^a   Yoshida, Yoko ^b   Wakimoto, Hlroaki ^b   Hamada, Hirofumi ^b   Kanegae, Yumi ^c   Saito, Izumu ^c   Nakabayashi, Hidekazu ^d   Tamaoki, Taiki ^d   Tanaka, Torao ^a   Lan, Keng Hsin ^a   Kato, Naoya ^a   Shiina, Shuichiro ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER INSTITUTE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF CALGARY   (Canada)

^e JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BETA ACTIN; GANCICLOVIR; THYMIDINE KINASE;

ADENOVIRUS; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CYTOTOXICITY; DRUG SENSITIVITY; DRUG SENSITIZATION; ENHANCER REGION; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HEPATOMA CELL; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; VIRUS RECOMBINANT;

EID: 15844416306     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v23.pm0008675152     Document Type: Article

References (15)

1. Levin B, Amos C. Therapy of unresectable hepatocellular carcinoma. N EngI J Med 1995;332:1294-1296.
2. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995;332:1256-1261.
3. Farmer DG, Busuttil RW. The role of multimodal therapy in the treatment of hepatocellular carcinoma. Cancer 1994;73:2669-2670.
4. Colombo M. Hepatocellular carcinoma. J Hepatology 1992;15: 225-236.
5. Venook AP. Treatment of hepatocellular carcinoma: too many options? J Clin Oncol 1994;12:1323-1334.
6. Gore ME, Collins MK. Gene therapy for cancer. Eur J Cancer 1994;30A:1047-1049.
7. Anderson WF. Gene therapy for cancer. Hum Gene Ther 1994; 5:1-2.
8. Gutierrez AA, Lemoine NR, Sikora K Gene therapy for cancer. Lancet 1992;339:715-721.
9. Abelev GI. Alpha-fetoprotein in oncogenesis and its association with malignant tumors. Adv Cancer Res 1971;14:295-358.
10. Nakabayashi H, Watanabe K, Saito A, Otsuru A, Sawadaishi K, Tamaoki T. Transcriptional regulation of α-fetoprotein expression by dexamethasone in human hepatoma cells. J Biol Chem 1989;264:266-271.
11. Sawadaishi K, Morinaga T, Tamaoki T. Interaction of a hepatoma-specific nuclear factor with transcription-regulatory sequences of the human α-fetoprotein and albumin genes. Mol Cell Biol 1988;8:5179-5187.
12. Watanabe K, Saito A, Tamaoki T. Cell-specific enhancer activity in a far upstream region of the human α-fetoprotein gene. J Biol Chem 1987;262:4812-4818.
13. Nakabayashi H, Hashimoto T, Miyao Y, Tjong K-K, Chan J, Tamaoki T. A position-dependent silencer plays a major role in repressing α-fetoprotein expression in human hepatoma. Mol Cell Biol 1991;11:5885-5893.
14. Nakata K, Motomura M, Nakabayashi H, Ido A, Tamaoki T. A possible mechanism of inverse developmental regulation of α-fetoprotein and albumin genes. J Biol Chem 1992;267:1331-1334.
15. Moolten FL. Tumor chemosensitivity conferred by inserted herpes simplex thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 1986;46:5276-5281.